Skip to content
Business Company News, Medical Health Aged Care

HeraMED Limited (ASX: HMD) Announces Live Implementation of HeraCARE at Broward Health, Florida

Jane Morgan Management 2 mins read

Highlights:

  • HeraCARE is now live at Broward Health, one of the largest public healthcare systems in the U.S.

  • The two-year agreement with Broward Health includes 700 HeraCARE licenses and 200 HeraBEAT devices.

  • The initial implementation has already registered 20 mothers, with plans to scale significantly.

  • The partnership aims to revolutionize maternal care with innovative telehealth solutions.

Melbourne, Australia - HeraMED Limited (ASX: HMD) ("HeraMED" or the "Company"), a leader in digital transformation of maternity care, is thrilled to announce the successful launch of its HeraCARE platform at Broward Health in Florida, USA. This marks a significant milestone as Broward Health becomes the first major U.S. healthcare system to implement HeraMED's remote monitoring solutions.

The initial rollout has seen 20 mothers onboarded, with plans to expand the implementation to support at least 700 pregnancies. This partnership, signed in February 2024, represents the largest deployment of remote monitoring solutions in the U.S. to date.

HeraMED Managing Director and CEO Anoushka Gungadin confirmed, “Working with Broward Health is hugely significant for HeraMED as we collaborate in an aligned vision to change maternity and pregnancy care and maternal outcomes. It is exciting to see the positive momentum and engagement with Broward mums as they experience the HeraCARE platform and HeraBEAT devices in their maternity care. We look forward to continuing to respond to the needs of Broward Health and mums, while supporting the delivery of the highest level of care, and provider-patient experience.” 

Rose McKelvie, Broward Health’s Associate Vice President of Women’s and Children’s Service Line added, “As part of the implementation, we have been impressed with the team at HeraMED including their focus on leading change in maternal care. Through the innovative technology brought to us via the innovative HeraCARE platform and its impressive configurability, we are delighted to be driving and leading the positive change in improving the health of expecting mothers as well as access to care during and after pregnancies at Broward Health.”


About us:

About HeraMED Limited:

HeraMED is an innovative medical data and technology company leading the digital transformation of maternity care by revolutionising the prenatal and postpartum experience with its hybrid maternity care platform. HeraMED offers a proprietary platform that utilises hardware and software to reshape the Doctor/Patient relationship using its clinically validated in-home foetal and maternal heart rate monitor, HeraBEAT, cloud computing, artificial intelligence, and big data. The Company’s proprietary offering, HeraCARE, has been engineered to offer a fully integrated maternal health ecosystem designed to deliver better care at a lower cost, ensure expectant mothers are engaged, informed and well-supported, allow healthcare professionals to provide the highest quality care and enable early detection and prevention of potential risks.

 


Contact details:

Jane Morgan 

[email protected]

Media

More from this category

  • Business Company News, Oil Mining Resources
  • 17/12/2025
  • 13:15
RocketDNA (ASX:RKT)

RocketDNA Receives ~A$1M in New Orders

HIGHLIGHTS New 12-month order fromBHP WAIO for dual xBot deployment Contract renewal and expansion atAssmang’s Khumani Iron Ore Mine, including a 12-month drone services extension and an additional 12-month xBot program Additional xBot units ordered by Norton Gold Fields Aggregate value of new binding contracts and purchase orders received of approximately A$1.0 million 17 December 2025, RocketDNA Ltd (ASX: RKT) (RocketDNA or the Company), a technology services company specialising in AI-powered drone data solutions, has received approximately A$1M in new purchase orders from existing customers, relating to the expansion of existing autonomous drone programs. These orders reflect increasing demand for…

  • Medical Health Aged Care
  • 17/12/2025
  • 13:11
GE HealthCare

GE HealthCare and Indonesia’s Ministry of Health to expand access to quality care through the provision of 300+ advanced CT scanners

300+ advanced CT scanners to be installed in public hospitals across 38 provinces by 2028, to support early diagnosis and treatment of non-communicable diseases.…

  • Contains:
  • Finance Investment, Medical Health Aged Care
  • 17/12/2025
  • 12:03
Jane Morgan Management

LTR Pharma surpasses 1,000 SPONTANĀ® prescriptions under TGA Special Access Scheme

Highlights More than 1,000 SPONTAN® prescriptions issued under the TGA Special Access Scheme Growing prescriber network with continued uptake in complex ED cases, including post-prostate cancer patients Real-world insights informing US commercial strategy ahead of ROXUS® launch in H1 CY2026 LTR Pharma Limited (ASX:LTP) (“LTR Pharma” or “the Company”) is pleased to announce that more than 1,000 SPONTAN® prescriptions have now been issued in Australia under the Therapeutic Goods Administration (TGA) Special Access Scheme (SAS Category B). SPONTAN is being prescribed for patients with unmet clinical needs, including men who have not achieved adequate benefit from traditional oral PDE5 inhibitor…

  • Contains:

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.